{"id":2981,"date":"2016-08-17T08:26:54","date_gmt":"2016-08-17T12:26:54","guid":{"rendered":"http:\/\/reprieveus.flywheelsites.com\/?page_id=2981"},"modified":"2017-08-18T10:37:35","modified_gmt":"2017-08-18T14:37:35","slug":"investors","status":"publish","type":"post","link":"https:\/\/reprieve.org\/us\/2016\/08\/17\/investors\/","title":{"rendered":"How investors can support affected pharmaceutical companies"},"content":{"rendered":"<h2><span>What role can investors play?<\/span><\/h2>\n<p>Investors and financial institutions have played a crucial role in protecting pharmaceutical companies from the risks associated with involvement in executions.<\/p>\n<p>In recent years, a number of investors have been instrumental in urging companies to act on this issue. In 2011, Unipension divested from Lundbeck because its pentobarbital was being used in US executions; a move that prompted the company to take strong and decisive action. The Danish Doctors Pension Fund was equally critical in convincing Hospira to change its position on the issue in 2013.<\/p>\n<p>&nbsp;<\/p>\n<h2><span>Is divestment the only option?<\/span><\/h2>\n<p>Reprieve respects the decision of some institutional investors that they would prefer not to hold any shares in companies who do not restrict the sale of their products for use in executions.<\/p>\n<p>Reprieve also recognises that there are a number of other ways concerned investors can proactively address this issue. Today, a growing number of investors on both sides of the Atlantic are engaging with the few remaining companies who do not have controls in place, encouraging them to implement watertight controls.<\/p>\n<p>&nbsp;<\/p>\n<h2><span>Investment and Pension Funds<\/span><\/h2>\n<p>In August of 2014 French bank BNP Paribas launched an initiative to build a formal coalition of investors willing to take action on this issue. Under the banner of the United Nations\u2019 Principles of Responsible Investment (UNPRI), BNP Paribas is encouraging all 1000+ signatories to the Principles to join with it in engaging the remaining affected pharmaceutical manufacturers. Investors seeking to join this initiative can review its initial call to action on the UNPRI website, or contact the team for more information via <a href=\"mailto:dan.dolan@reprieve.org.uk.\">dan.dolan@reprieve.org.uk.<\/a><\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: center;\"><a class=\"button\" style=\"color: #ffffff;\" href=\"https:\/\/secure.reprieve.org\/page\/s\/join-our-mailing-list\">Join Reprieve US<\/a> <a class=\"button\" style=\"color: #ffffff;\" href=\"https:\/\/secure.reprieve.org\/page\/contribute\/donate-now\">Donate now<\/a> <a class=\"button\" style=\"color: #ffffff;\" href=\"https:\/\/twitter.com\/home?status=https%3A\/\/reprieve.org\/lethal-injection\/investors\/\">Share on Twitter<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Investors and financial institutions play a crucial role in protecting pharmaceutical companies from the risks associated with involvement in executions.<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[],"tags":[],"class_list":["post-2981","post","type-post","status-publish","format-standard","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>How investors can support affected pharmaceutical companies<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/reprieve.org\/us\/2016\/08\/17\/investors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How investors can support affected pharmaceutical companies\" \/>\n<meta property=\"og:description\" content=\"Investors and financial institutions play a crucial role in protecting pharmaceutical companies from the risks associated with involvement in executions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/reprieve.org\/us\/2016\/08\/17\/investors\/\" \/>\n<meta property=\"og:site_name\" content=\"Reprieve US\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ReprieveUSA\" \/>\n<meta property=\"article:published_time\" content=\"2016-08-17T12:26:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-08-18T14:37:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/reprieve.org\/wp-content\/uploads\/sites\/3\/2021\/06\/Reprieve_MetaImage_Logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@reprieveus\" \/>\n<meta name=\"twitter:site\" content=\"@reprieveus\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/reprieve.org\\\/us\\\/2016\\\/08\\\/17\\\/investors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/reprieve.org\\\/us\\\/2016\\\/08\\\/17\\\/investors\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"How investors can support affected pharmaceutical companies\",\"datePublished\":\"2016-08-17T12:26:54+00:00\",\"dateModified\":\"2017-08-18T14:37:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/reprieve.org\\\/us\\\/2016\\\/08\\\/17\\\/investors\\\/\"},\"wordCount\":284,\"publisher\":{\"@id\":\"https:\\\/\\\/reprieve.org\\\/us\\\/#organization\"},\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/reprieve.org\\\/us\\\/2016\\\/08\\\/17\\\/investors\\\/\",\"url\":\"https:\\\/\\\/reprieve.org\\\/us\\\/2016\\\/08\\\/17\\\/investors\\\/\",\"name\":\"How investors can support affected pharmaceutical companies\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/reprieve.org\\\/us\\\/#website\"},\"datePublished\":\"2016-08-17T12:26:54+00:00\",\"dateModified\":\"2017-08-18T14:37:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/reprieve.org\\\/us\\\/2016\\\/08\\\/17\\\/investors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/reprieve.org\\\/us\\\/2016\\\/08\\\/17\\\/investors\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/reprieve.org\\\/us\\\/2016\\\/08\\\/17\\\/investors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/reprieve.org\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How investors can support affected pharmaceutical companies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/reprieve.org\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/reprieve.org\\\/us\\\/\",\"name\":\"Reprieve - fighting for human rights around the world\",\"description\":\"Reprieve US\",\"publisher\":{\"@id\":\"https:\\\/\\\/reprieve.org\\\/us\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/reprieve.org\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/reprieve.org\\\/us\\\/#organization\",\"name\":\"Reprieve US\",\"url\":\"https:\\\/\\\/reprieve.org\\\/us\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/reprieve.org\\\/us\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Reprieve US\"},\"image\":{\"@id\":\"https:\\\/\\\/reprieve.org\\\/us\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ReprieveUSA\",\"https:\\\/\\\/x.com\\\/reprieveus\"]},{\"@type\":\"Person\",\"@id\":\"\",\"url\":\"https:\\\/\\\/reprieve.org\\\/us\\\/author\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"How investors can support affected pharmaceutical companies","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/reprieve.org\/us\/2016\/08\/17\/investors\/","og_locale":"en_US","og_type":"article","og_title":"How investors can support affected pharmaceutical companies","og_description":"Investors and financial institutions play a crucial role in protecting pharmaceutical companies from the risks associated with involvement in executions.","og_url":"https:\/\/reprieve.org\/us\/2016\/08\/17\/investors\/","og_site_name":"Reprieve US","article_publisher":"https:\/\/www.facebook.com\/ReprieveUSA","article_published_time":"2016-08-17T12:26:54+00:00","article_modified_time":"2017-08-18T14:37:35+00:00","og_image":[{"width":1000,"height":500,"url":"https:\/\/reprieve.org\/wp-content\/uploads\/sites\/3\/2021\/06\/Reprieve_MetaImage_Logo.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_creator":"@reprieveus","twitter_site":"@reprieveus","twitter_misc":{"Written by":"","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/reprieve.org\/us\/2016\/08\/17\/investors\/#article","isPartOf":{"@id":"https:\/\/reprieve.org\/us\/2016\/08\/17\/investors\/"},"author":{"name":"","@id":""},"headline":"How investors can support affected pharmaceutical companies","datePublished":"2016-08-17T12:26:54+00:00","dateModified":"2017-08-18T14:37:35+00:00","mainEntityOfPage":{"@id":"https:\/\/reprieve.org\/us\/2016\/08\/17\/investors\/"},"wordCount":284,"publisher":{"@id":"https:\/\/reprieve.org\/us\/#organization"},"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/reprieve.org\/us\/2016\/08\/17\/investors\/","url":"https:\/\/reprieve.org\/us\/2016\/08\/17\/investors\/","name":"How investors can support affected pharmaceutical companies","isPartOf":{"@id":"https:\/\/reprieve.org\/us\/#website"},"datePublished":"2016-08-17T12:26:54+00:00","dateModified":"2017-08-18T14:37:35+00:00","breadcrumb":{"@id":"https:\/\/reprieve.org\/us\/2016\/08\/17\/investors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/reprieve.org\/us\/2016\/08\/17\/investors\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/reprieve.org\/us\/2016\/08\/17\/investors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/reprieve.org\/us\/"},{"@type":"ListItem","position":2,"name":"How investors can support affected pharmaceutical companies"}]},{"@type":"WebSite","@id":"https:\/\/reprieve.org\/us\/#website","url":"https:\/\/reprieve.org\/us\/","name":"Reprieve - fighting for human rights around the world","description":"Reprieve US","publisher":{"@id":"https:\/\/reprieve.org\/us\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/reprieve.org\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/reprieve.org\/us\/#organization","name":"Reprieve US","url":"https:\/\/reprieve.org\/us\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/reprieve.org\/us\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Reprieve US"},"image":{"@id":"https:\/\/reprieve.org\/us\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ReprieveUSA","https:\/\/x.com\/reprieveus"]},{"@type":"Person","@id":"","url":"https:\/\/reprieve.org\/us\/author\/"}]}},"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"Reprieve US","distributor_original_site_url":"https:\/\/reprieve.org\/us","push-errors":false,"_links":{"self":[{"href":"https:\/\/reprieve.org\/us\/wp-json\/wp\/v2\/posts\/2981","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/reprieve.org\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/reprieve.org\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/reprieve.org\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/reprieve.org\/us\/wp-json\/wp\/v2\/comments?post=2981"}],"version-history":[{"count":0,"href":"https:\/\/reprieve.org\/us\/wp-json\/wp\/v2\/posts\/2981\/revisions"}],"wp:attachment":[{"href":"https:\/\/reprieve.org\/us\/wp-json\/wp\/v2\/media?parent=2981"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/reprieve.org\/us\/wp-json\/wp\/v2\/categories?post=2981"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/reprieve.org\/us\/wp-json\/wp\/v2\/tags?post=2981"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}